Cited by 414Bone Metabolism and DiseasesRheumatoid Arthritis Research and TherapiesImmune Response and Inflammation

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Mechanistic insight into osteoclast differentiation in osteoimmunology

Takayanagi, Hiroshi·2005·Journal of Molecular Medicine

Open this paper in CoChat — free account

Abstract

Recently a close relationship between the immune and skeletal systems or the interdisciplinary field called osteoimmunology has attracted much attention due to the observations that bone destruction is caused by an abnormal activation of the immune system in rheumatoid arthritis, and that mice lacking immunomodulatory molecules often exhibit an unexpected bone phenotype. Osteoclasts are cells of monocyte/macrophage origin that degrade the bone matrix. They are among the key players in the control of bone metabolism in health and disease. Receptor activator of NF-kappaB ligand (RANKL), a tumor necrosis factor (TNF) family cytokine, induces the differentiation of osteoclasts in the presence of macrophage-colony stimulating factor. RANKL activates TRAF6, c-Fos, and calcium signaling pathways, all of which are indispensable for the induction and activation of nuclear factor of activated T cells (NFAT) c1, the master transcription factor for osteoclastogenesis. The autoamplification of NFATc1 gene results in the efficient induction of osteoclast-specific genes. An AP-1 transcription factor complex containing c-Fos plays a crucial role in these processes, although results in conditional knockout mice show that Jun family members have a redundant role. The immunoreceptor tyrosine-based activation motif (ITAM) is an important signaling component for a number of receptors in the immune system including T-cell, B-cell, NK-cell, and Fc receptors, but its contribution to the skeletal sys…

Integrity signals

Registry

Crossref · 10.1007/s00109-004-0612-6

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Muñoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E. V., Bock, C. –., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,700
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 1×
“Based on the fact that the addition of RANKL and M-CSF can induce osteoclast differentiation in culture, it has been generally believed that RANKL and M-CSF are not only essential but also sufficient for osteoclastogenesis [24].”
Background
The versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Self-citation
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C. H., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,592
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345

Show all 76 references

Sorted by citations

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Self-citation
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Self-citation
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Self-citation
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Nishina, H., & Penninger, J. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,230
Biology of RANK, RANKL, and osteoprotegerin
Boyce, B. F., & Xing, L. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2165 · Cited by 994
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051150 · Cited by 849
Self-citation
OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism
Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., & Choi, Y. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090646 · Cited by 724
Biology of the RANKLâ€“RANKâ€“OPG System in Immunity, Bone, and Beyond
Walsh, M. C., & Choi, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00511 · Cited by 599
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M. C., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 576
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
NFAT and Osterix cooperatively regulate bone formation
Koga, T., Matsui, Y., Asagiri, M., Kodama, T., Crombrugghe, B. D., Nakashima, K., & Takayanagi, H. (2005) · Nature Medicine · doi:10.1038/nm1270 · Cited by 497
Self-citation
Inflammatory mediators in the pathogenesis of periodontitis
Yucel‐Lindberg, T., & Båge, T. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.8 · Cited by 473
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1
Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I. R., Schwarz, E. M., Takeshita, S., Wagner, E. F., Noda, M., Matsuo, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610701200 · Cited by 414
The Early Fracture Hematoma and Its Potential Role in Fracture Healing
Kolar, P., Schmidt‐Bleek, K., Schell, H., Gaber, T., Toben, D., Schmidmaier, G., Perka, C., Buttgereit, F., & Duda, G. N. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0687 · Cited by 422
Bone Remodeling in Post-menopausal Osteoporosis
Lerner, U. H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500703 · Cited by 354
The RANKL/RANK/OPG pathway
Boyce, B. F., & Xing, L. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0024-y · Cited by 339
Immunology of Osteoporosis: A Mini-Review
Pietschmann, P., Mechtcheriakova, D., Meshcheryakova, A., Föger‐Samwald, U., & Ellinger, I. (2015) · Gerontology · doi:10.1159/000431091 · Cited by 291
Inflammatory bone destruction and osteoimmunology
Takayanagi, H. (2005) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00814.x · Cited by 272
Self-citation
MafB negatively regulates RANKL-mediated osteoclast differentiation
Kim, K., Kim, J. H., Lee, J., Jin, H. M., Kook, H. Y., Kim, K. K., Lee, S. Y., & Kim, N. (2006) · Blood · doi:10.1182/blood-2006-09-048249 · Cited by 264
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 264
Mechanisms and control of pathologic bone loss in periodontitis
Bartold, P. M., Cantley, M. D., & Haynes, D. R. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00347.x · Cited by 252
Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis
Kim, K., Kim, J. H., Lee, J., Jin, H., Lee, S., Fisher, D. E., Kook, H. Y., Kim, K. K., Choi, Y., & Kim, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505815200 · Cited by 247
Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone
Humphrey, M. B., Lanier, L. L., & Nakamura, M. C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00325.x · Cited by 244
Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling
Ramesh, P., Jagadeesan, R., Sekaran, S., Dhanasekaran, A., & Vimalraj, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.779638 · Cited by 247
Osteoclast precursors, RANKL/RANK, and immunology
Xing, L., Schwarz, E. M., & Boyce, B. F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00336.x · Cited by 236
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Self-citation
RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for Osteoclastogenesis
Kim, M. S., Yang, Y., Son, A., Tian, Y. S., Lee, S.-I., Kang, S. W., Muallem, S., & Shin, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051557 · Cited by 207
Contribution of Nuclear Factor of Activated T Cells c1 to the Transcriptional Control of Immunoreceptor Osteoclast-associated Receptor but Not Triggering Receptor Expressed by Myeloid Cells-2 during Osteoclastogenesis
Kim, Y., Sato, K., Asagiri, M., Morita, I., Soma, K., & Takayanagi, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505820200 · Cited by 199
Self-citation
Osteoclasts Have Multiple Roles in Bone in Addition to Bone Resorption
Boyce, B. F., Yao, Z., & Xing, L. (2009) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i3.10 · Cited by 214
Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
Soltanoff, C. S., Yang, S., Chen, W., & Li, Y. (2009) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.10 · Cited by 201
High glucose concentrations alter the biomineralization process in human osteoblastic cells
García‐Hernández, A. L., Arzate, H., Gil-Chavarría, I., Rojo, R., & Moreno‐Fierros, L. (2011) · Bone · doi:10.1016/j.bone.2011.10.032 · Cited by 216
Interplay between interferon and other cytokine systems in bone metabolism
Takayanagi, H., Sato, K., Takaoka, A., & Taniguchi, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00337.x · Cited by 192
Self-citation
Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis
Schmidt‐Bleek, K., Kwee, B. J., Mooney, D. J., & Duda, G. N. (2015) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0677 · Cited by 187
Regulation of osteoclast function and bone mass by RAGE
Zhou, Z., Immel, D., Xi, C.-X., Bierhaus, A., Feng, X., Mei, L., Nawroth, P., Stern, D. M., & Xiong, W.-C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051947 · Cited by 178
TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
Walsh, M. C., Kim, G. K., Maurizio, P. L., Molnar, E. E., & Choi, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004064 · Cited by 178
Inhibition of Hormone and Cytokine-stimulated Osteoclastogenesis and Bone Resorption by Interleukin-4 and Interleukin-13 Is Associated with Increased Osteoprotegerin and Decreased RANKL and RANK in a STAT6-dependent Pathway
Palmqvist, P., Lundberg, P., Persson, E., Johansson, A., Lundgren, I., Lie, A., Conaway, H. H., & Lerner, U. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510160200 · Cited by 167
Role of nuclear factor‐κB in the immune system and bone
Jimi, E., & Ghosh, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00329.x · Cited by 167
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway
Huang, H., Chang, E.-J., Ryu, J., Lee, Z. H., Lee, Y., & Kim, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.011 · Cited by 164
HMGB1 Regulates RANKL-Induced Osteoclastogenesis in a Manner Dependent on RAGE
Zhou, Z., Han, J.-Y., Xi, C.-X., Xie, J.-X., Feng, X., Wang, C.-Y., Mei, L., & Xiong, W.-C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080234 · Cited by 160
Calcineurin regulates bone formation by the osteoblast
Sun, L., Blair, H. C., Peng, Y., Zaidi, N., Adebanjo, O. A., Wu, X. B., Wu, X. Y., Iqbal, J. Z., Epstein, S., Abe, E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508480102 · Cited by 159
MicroRNA-124 regulates osteoclast differentiation
Lee, Y., Kim, H. J., Park, C., Kim, Y., Lee, H., Kim, J., & Kim, H. (2013) · Bone · doi:10.1016/j.bone.2013.07.007 · Cited by 159
Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN-γ in Human Osteoclast Precursors
Ji, J.-D., Park‐Min, K., Shen, Z., Fajardo, R. J., Goldring, S. R., McHugh, K. P., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900072 · Cited by 162
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts
Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K., & Miyasaka, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2046 · Cited by 159
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1
Anderson, G., Gries, M., Kurihara, N., Honjo, T., Anderson, J., Donnenberg, V. S., Donnenberg, A. D., Ghobrial, I. M., Mapara, M. Y., Stirling, D., et al. (2005) · Blood · doi:10.1182/blood-2005-08-3450 · Cited by 148
Roles of Cyclic AMP Response Element Binding Activation in the ERK1/2 and p38 MAPK Signalling Pathway in Central Nervous System, Cardiovascular System, Osteoclast Differentiation and Mucin and Cytokine Production
Koga, Y., Tsurumaki, H., Aoki‐Saito, H., Sato, M., Yatomi, M., Takehara, K., & Hisada, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061346 · Cited by 152
TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3
Besse, A., Lamothe, B., Campos, A. D., Webster, W. K., Maddineni, U., Lin, S., Wu, H., & Darnay, B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608867200 · Cited by 147
Secretion of tartrate‐resistant acid phosphatase by osteoclasts correlates with resorptive behavior
Kirstein, B., Chambers, T. J., & Fuller, K. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20835 · Cited by 145
Schmorl’s nodes
Kyere, K. A., Than, K. D., Wang, A., Rahman, S. U., Valdivia–Valdivia, J. M., Marca, F. L., & Park, P. (2012) · European Spine Journal · doi:10.1007/s00586-012-2325-9 · Cited by 143
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation
Lamothe, B., Webster, W. K., Gopinathan, A., Besse, A., Campos, A. D., & Darnay, B. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.017 · Cited by 134
Osteoclast differentiation and gene regulation
Zhao, Q. (2006) · Frontiers in bioscience · doi:10.2741/2252 · Cited by 129
Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12
Kameda, Y., Takahata, M., Komatsu, M., Mikuni, S., Hatakeyama, S., Shimizu, T., Angata, T., Kinjo, M., Minami, A., & Iwasaki, N. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1989 · Cited by 128
The Regulation of Cathepsin K Gene Expression
Troen, B. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.018 · Cited by 128
IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-κB Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
Park‐Min, K., Ji, J.-D., Antoniv, T. T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M. C., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804165 · Cited by 123
Roles of receptor activator of nuclear factor‐κB ligand (RANKL) and osteoprotegerin in periodontal health and disease
Nagasawa, T., Kiji, M., Yashiro, R., Hormdee, D., Lu, H., Kunze, M., Suda, T., Koshy, G., Kobayashi, H., Oda, S., et al. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00185.x · Cited by 123
Pathological role of osteoclast costimulation in arthritis-induced bone loss
Ochi, S., Shinohara, M., Sato, K., Gober, H.-J., Koga, T., Kodama, T., Takai, T., Miyasaka, N., & Takayanagi, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701971104 · Cited by 123
Self-citation
Mechanisms of Disease: molecular insights into aseptic loosening of orthopedic implants
Drees, P., Eckardt, A., Gay, R. E., Gay, S., & Huber, L. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0428 · Cited by 119
Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss
Crotti, T. N., Dharmapatni, A. A. S. S. K., Alias, E., & Haynes, D. R. (2015) · Journal of Immunology Research · doi:10.1155/2015/281287 · Cited by 113
Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells
Kiesel, J. R., Buchwald, Z. S., & Aurora, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803897 · Cited by 109
The effects of tumour necrosis factor‐α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes
Algate, K., Haynes, D. R., Bartold, P. M., Crotti, T. N., & Cantley, M. D. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12339 · Cited by 108
The role of SH3BP2 in the pathophysiology of cherubism
Reichenberger, E., Levine, M. A., Olsen, B. R., Papadaki, M. E., & Lietman, S. A. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-s1-s5 · Cited by 110
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice
Kim, H., Choi, H. K., Shin, J. H., Kim, K., Huh, J. Y., Lee, S. A., Ko, C., Kim, H.-S., Shin, H.-I., Jeong, D., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36809 · Cited by 106
Cellular and molecular pathways of structural damage in rheumatoid arthritis
Steffen, U., & Schett, G. A. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0634-0 · Cited by 105
Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis
Joyce-Shaikh, B., Bigler, M. E., Chao, C., Murphy, E. E., Blumenschein, W. M., Adamopoulos, I. E., Heyworth, P. G., Antonenko, S. V., Bowman, E. P., McClanahan, T. K., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20090516 · Cited by 103
Wnt signalling pathway: a new target for the treatment of osteoporosis
Rawadi, G., & Roman‐Roman, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1063 · Cited by 94
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents
Fuller, K., Kirstein, B., & Chambers, T. J. (2005) · Endocrinology · doi:10.1210/en.2005-1340 · Cited by 89
Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
Kalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27200 · Cited by 90
Bisphosphonates, Old Friends of Bones and New Trends in Clinics
Barbosa, J. S., Paz, F. A. A., & Braga, S. S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01292 · Cited by 89
TRAFs in RANK Signaling
Darnay, B. G., Besse, A., Poblenz, A. T., Lamothe, B., & Jacoby, J. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_12 · Cited by 85
Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis
Cantley, M. D., Fairlie, D. P., Bartold, P. M., Marino, V., Gupta, P. K., & Haynes, D. R. (2015) · Rheumatology · doi:10.1093/rheumatology/kev022 · Cited by 83
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
Wu, H., Hu, B., Zhou, X., Zhou, C., Meng, J., Yang, Y., Zhao, X., Shi, Z., & Yan, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0540-y · Cited by 81
Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis
Venkatesha, S. H., Berman, B., & Moudgil, K. D. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.053 · Cited by 80
Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival
Seales, E. C., Micoli, K., & McDonald, J. M. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20659 · Cited by 80
Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1
Kwak, H. B., Yang, D., Ha, H., Lee, J.-H., Kim, H., Woo, E.-R., Lee, S., Kim, H., & Lee, Z. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.31 · Cited by 77
Kaempferol Inhibits IL-1β-Stimulated, RANKL-mediated Osteoclastogenesis via Downregulation of MAPKs, c-Fos, and NFATc1
Lee, W., Lee, E., Sung, M.-S., & Yoo, W. (2014) · Inflammation · doi:10.1007/s10753-014-9849-6 · Cited by 78
Inflammation-Induced Bone Loss: Can it Be Prevented?
Romas, E., & Gillespie, M. T. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.07.004 · Cited by 78
Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways
Shang, W., Zhao, L.-J., Dong, X., Zhao, Z.-M., Li, J., Zhang, B., & Cai, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5674 · Cited by 77
BSP and RANKL Induce Osteoclastogenesis and Bone Resorption Synergistically
Valverde, P., Tu, Q., & Chen, J. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050511 · Cited by 76
VEGF and RANKL Regulation of NFATc1 in Heart Valve Development
Combs, M. D., & Yutzey, K. E. (2009) · Circulation Research · doi:10.1161/circresaha.109.196469 · Cited by 76
Smoking modulates interleukin‐6:interleukin‐10 and RANKL:osteoprotegerin ratios in the periodontal tissues
César‐Neto, J. B., Duarte, P. M., Oliveira, M. C. G., Tambeli, C. H., Sallum, E. A., & Nociti, F. H. (2006) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2006.00934.x · Cited by 76
Water-soluble fullerene (c60) inhibits the development of arthritis in the rat model of arthritis
Yudoh, K. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s7653 · Cited by 75
Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis
Li, B., Wang, P., Jiao, J., Wei, H., Xu, W., & Zhou, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824117 · Cited by 79
Acteoside Suppresses RANKL-Mediated Osteoclastogenesis by Inhibiting c-Fos Induction and NF-κB Pathway and Attenuating ROS Production
Lee, S.-Y., Lee, K.-S., Yi, S. H., Kook, S., & Lee, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080873 · Cited by 72
Novel osteoclast signaling mechanisms
Shinohara, M., & Takayanagi, H. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0005-1 · Cited by 72
Self-citation
Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanisms
Pike, J. W., Lee, S. M., & Meyer, M. B. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.216 · Cited by 74
Bone inflammation and altered gene expression with type I diabetes early onset
Motyl, K. J., Boțolin, S., Irwin, R., Appledorn, D. M., Kadakia, T., Amalfitano, A., Schwartz, R. C., & McCabe, L. R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21626 · Cited by 71
Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide
Liu, F., Zhu, Z., Mao, Y., Liu, M., Tang, T., & Qiu, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.018 · Cited by 71
Clastic cells: Mineralized tissue resorption in health and disease
Arana-Chavez, V. E., & Bradaschia-Correa, V. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.007 · Cited by 69
Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation
Tsubaki, M., Komai, M., Itoh, T., Imano, M., Sakamoto, K., Shimaoka, H., Takeda, T., Ogawa, N., Mashimo, K., Fujiwara, D., et al. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-10 · Cited by 70
Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling
Thummuri, D., Naidu, V. G. M., & Chaudhari, P. R. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1553-1 · Cited by 69
Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand
Balkan, W., Martinez, A. F., Fernández, I. C., Rodriguez, M. A., Pang, M., & Troen, B. R. (2009) · Gene · doi:10.1016/j.gene.2009.06.013 · Cited by 68
Osteoclasts—the innate immune cells of the bone
Wu, Y., Humphrey, M. B., & Nakamura, M. C. (2008) · Autoimmunity · doi:10.1080/08916930701693180 · Cited by 69
AP‐1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors
Pang, M., Rodríguez‐Gonzalez, M., Hernandez, M., Recinos, C. C., Seldeen, K. L., & Troen, B. R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28504 · Cited by 67
Inhibitory effect of luteolin on osteoclast differentiation and function
Lee, J., Ahn, J.-Y., Hasegawa, S., Cha, B., Yonezawa, T., Nagai, K., Seo, H.-J., Jeon, W., & Woo, J. (2009) · Cytotechnology · doi:10.1007/s10616-010-9253-5 · Cited by 64
Inositol Polyphosphate 4-Phosphatase B as a Regulator of Bone Mass in Mice and Humans
Ferron, M., Boudiffa, M., Arsenault, M., Rached, M., Pata, M., Giroux, S., Elfassihi, L., Kisseleva, M. V., Majerus, P. W., Rousseau, F., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.013 · Cited by 62
MSU crystal deposition contributes to inflammation and immune responses in gout remission
Gu, H., Yu, H., Qin, L., Yu, H., Song, Y., Chen, G., Zhao, D., Wang, S., Xue, W., Wang, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113139 · Cited by 59
Cytokines and Bone Remodeling
Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 59
Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases
Zhu, S., Yan, M.-Q., Masson, A., Chen, W. "., & Li, Y. (2026) · Cell Discovery · doi:10.1038/s41421-025-00853-6 · Cited by 70

Authors: Takayanagi, H.
Affiliations: Tokyo Medical and Dental University (JP)
Corresponding author: Takayanagi, Hiroshi
Venue: Journal of Molecular Medicine
Publisher: Springer Science and Business Media LLC
Published: 2005-01-26
Volume: 83
Issue: 3
Pages: 170-179
ISSN: 0946-2716 (ISSN-L)
1432-1440
DOI: 10.1007/s00109-004-0612-6
OpenAlex: W2124273389
Cited by: 413
References: 76
Citations by year: 2026: 3 · 2025: 11 · 2024: 4 · 2023: 8 · 2022: 5 · 2021: 11 · 2020: 14 · 2019: 10 · 2018: 13 · 2017: 17 · 2016: 16 · 2015: 24 · 2014: 24 · 2013: 18 · 2012: 26
FWCI: 3.42
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Journal of Molecular Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Takeda Science Foundation
Mitsubishi Foundation
Japan Society for the Promotion of Science
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords: osteoclastogenesis, osteoimmunology, RANKL, TRAF6, c-fos, NFATc1, AP-1, ITAM signaling, FcRγ, DAP12, osteoclast-associated receptor, traps, TLR2, TLR4, phospholipase C-gamma, calcium signaling
MeSH terms: Animals, Carrier Proteins, Cell Differentiation, Humans, Membrane Glycoproteins, Osteoclasts, Receptors, Immunologic, Transcription Factors, Signal Transduction, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanistic insight into osteoclast differentiation in osteoimmunology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks